根据《世界反兴奋剂条例》接受药物检测的美国精英运动员使用兴奋剂的普遍程度。

IF 4.1 2区 医学 Q1 SPORT SCIENCES
Ann Kearns Davoren, Kelly Rulison, Jeff Milroy, Pauline Grist, Matthew Fedoruk, Laura Lewis, David Wyrick
{"title":"根据《世界反兴奋剂条例》接受药物检测的美国精英运动员使用兴奋剂的普遍程度。","authors":"Ann Kearns Davoren, Kelly Rulison, Jeff Milroy, Pauline Grist, Matthew Fedoruk, Laura Lewis, David Wyrick","doi":"10.1186/s40798-024-00721-9","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Determining the prevalence of doping within an elite athlete population is challenging due to the extreme sensitivity of the topic; however, understanding true doping prevalence is important when designing anti-doping programs and measuring their effectiveness. The objective of this study was to estimate the prevalence of doping among Olympic, Paralympic, World, and National-level competitive athletes in the United States subject to the World Anti-Doping Code. All athletes who were subject to the U.S. Anti-Doping Agency's Protocol for Olympic and Paralympic Movement Testing, a World Anti-Doping Code (\"Code\")-compliant anti-doping program, were invited to complete a web-delivered survey. Using a direct questioning approach, the survey items asked athletes whether they had used each specific category of banned substance / method on the World Anti-Doping Agency's Prohibited List. Multiple strategies to encourage honest reporting (e.g., protecting anonymity by collecting minimal demographic information; using an outside organization to administer the survey) and to detect inconsistent responses were used.</p><p><strong>Results: </strong>Depending on the method of calculation, 6.5-9.2% of the 1,398 respondents reported using one or more prohibited substances or methods in the 12 months prior to survey administration. Specific doping prevalence rates for each individual substance / method categories ranged from 0.1% (for both diuretics / masking agents and stem cell / gene editing) to 4.2% for in-competition use of cannabinoids.</p><p><strong>Conclusion: </strong>Determining the prevalence of doping within different athlete populations is critical so that sport governing bodies can evaluate their anti-doping efforts and better tailor their programming. By measuring doping prevalence of specific categories of substances and methods, rather than just the overall prevalence of doping, this study also highlights where sport governing bodies should focus their future educational and detection efforts.</p>","PeriodicalId":21788,"journal":{"name":"Sports Medicine - Open","volume":"10 1","pages":"57"},"PeriodicalIF":4.1000,"publicationDate":"2024-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11102888/pdf/","citationCount":"0","resultStr":"{\"title\":\"Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.\",\"authors\":\"Ann Kearns Davoren, Kelly Rulison, Jeff Milroy, Pauline Grist, Matthew Fedoruk, Laura Lewis, David Wyrick\",\"doi\":\"10.1186/s40798-024-00721-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Determining the prevalence of doping within an elite athlete population is challenging due to the extreme sensitivity of the topic; however, understanding true doping prevalence is important when designing anti-doping programs and measuring their effectiveness. The objective of this study was to estimate the prevalence of doping among Olympic, Paralympic, World, and National-level competitive athletes in the United States subject to the World Anti-Doping Code. All athletes who were subject to the U.S. Anti-Doping Agency's Protocol for Olympic and Paralympic Movement Testing, a World Anti-Doping Code (\\\"Code\\\")-compliant anti-doping program, were invited to complete a web-delivered survey. Using a direct questioning approach, the survey items asked athletes whether they had used each specific category of banned substance / method on the World Anti-Doping Agency's Prohibited List. Multiple strategies to encourage honest reporting (e.g., protecting anonymity by collecting minimal demographic information; using an outside organization to administer the survey) and to detect inconsistent responses were used.</p><p><strong>Results: </strong>Depending on the method of calculation, 6.5-9.2% of the 1,398 respondents reported using one or more prohibited substances or methods in the 12 months prior to survey administration. Specific doping prevalence rates for each individual substance / method categories ranged from 0.1% (for both diuretics / masking agents and stem cell / gene editing) to 4.2% for in-competition use of cannabinoids.</p><p><strong>Conclusion: </strong>Determining the prevalence of doping within different athlete populations is critical so that sport governing bodies can evaluate their anti-doping efforts and better tailor their programming. By measuring doping prevalence of specific categories of substances and methods, rather than just the overall prevalence of doping, this study also highlights where sport governing bodies should focus their future educational and detection efforts.</p>\",\"PeriodicalId\":21788,\"journal\":{\"name\":\"Sports Medicine - Open\",\"volume\":\"10 1\",\"pages\":\"57\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2024-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11102888/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sports Medicine - Open\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40798-024-00721-9\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"SPORT SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sports Medicine - Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40798-024-00721-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SPORT SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

背景:确定精英运动员群体中使用兴奋剂的普遍程度具有挑战性,因为这个问题极其敏感;然而,了解使用兴奋剂的真实普遍程度对于设计反兴奋剂计划和衡量其效果非常重要。本研究的目的是估算美国奥运、残奥会、世界和国家级竞技运动员中使用兴奋剂的流行率,这些运动员均须遵守《世界反兴奋剂条例》。所有接受美国反兴奋剂机构《奥运会和残奥会运动兴奋剂检查议定书》(一项符合《世界反兴奋剂条例》("条例")的反兴奋剂计划)检查的运动员都受邀完成了一项网络调查。调查项目采用直接提问的方式,询问运动员是否使用过《世界反兴奋剂机构禁用清单》上的每一类特定禁用物质/方法。我们采用了多种策略来鼓励诚实报告(例如,通过收集最低限度的人口信息来保护匿名性;使用外部机构来管理调查),并检测不一致的回答:根据不同的计算方法,在 1398 名受访者中,6.5%-9.2% 的受访者报告在调查实施前的 12 个月内使用过一种或多种禁用物质或禁用方法。每种物质/方法的具体使用率从 0.1%(利尿剂/掩蔽剂和干细胞/基因编辑)到 4.2%(赛内使用大麻素)不等:确定不同运动员群体中使用兴奋剂的普遍程度至关重要,这样体育管理机构才能评估其反兴奋剂工作,并更好地调整其计划。通过测量特定类别物质和方法的兴奋剂使用率,而不仅仅是兴奋剂的总体使用率,本研究还强调了体育管理机构未来教育和检测工作的重点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Doping Prevalence among U.S. Elite Athletes Subject to Drug Testing under the World Anti-Doping Code.

Background: Determining the prevalence of doping within an elite athlete population is challenging due to the extreme sensitivity of the topic; however, understanding true doping prevalence is important when designing anti-doping programs and measuring their effectiveness. The objective of this study was to estimate the prevalence of doping among Olympic, Paralympic, World, and National-level competitive athletes in the United States subject to the World Anti-Doping Code. All athletes who were subject to the U.S. Anti-Doping Agency's Protocol for Olympic and Paralympic Movement Testing, a World Anti-Doping Code ("Code")-compliant anti-doping program, were invited to complete a web-delivered survey. Using a direct questioning approach, the survey items asked athletes whether they had used each specific category of banned substance / method on the World Anti-Doping Agency's Prohibited List. Multiple strategies to encourage honest reporting (e.g., protecting anonymity by collecting minimal demographic information; using an outside organization to administer the survey) and to detect inconsistent responses were used.

Results: Depending on the method of calculation, 6.5-9.2% of the 1,398 respondents reported using one or more prohibited substances or methods in the 12 months prior to survey administration. Specific doping prevalence rates for each individual substance / method categories ranged from 0.1% (for both diuretics / masking agents and stem cell / gene editing) to 4.2% for in-competition use of cannabinoids.

Conclusion: Determining the prevalence of doping within different athlete populations is critical so that sport governing bodies can evaluate their anti-doping efforts and better tailor their programming. By measuring doping prevalence of specific categories of substances and methods, rather than just the overall prevalence of doping, this study also highlights where sport governing bodies should focus their future educational and detection efforts.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Sports Medicine - Open
Sports Medicine - Open SPORT SCIENCES-
CiteScore
7.00
自引率
4.30%
发文量
142
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信